在脓毒症中打破四旋蛋白与高迁移率族蛋白 B1 的结合。
Breaking the bond between tetranectin and HMGB1 in sepsis.
机构信息
Department of Surgery and Emory Critical Care Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
Medical Corps, United States Navy, NROTC Atlanta, GA, USA.
出版信息
Sci Transl Med. 2020 Apr 15;12(539). doi: 10.1126/scitranslmed.abb2575.
Abstract
The interaction between tetranectin and high-mobility group box-1 protein may be manipulated via monoclonal antibodies to improve survival in sepsis (Chen same issue).
摘要
四连接蛋白与高迁移率族蛋白 B1 之间的相互作用可以通过单克隆抗体来操纵，以改善脓毒症患者的存活率（Chen 同期刊物）。
相似文献
1
Breaking the bond between tetranectin and HMGB1 in sepsis.在脓毒症中打破四旋蛋白与高迁移率族蛋白 B1 的结合。
Sci Transl Med. 2020 Apr 15;12(539). doi: 10.1126/scitranslmed.abb2575.
2
Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis.鉴定针对四连接蛋白的单克隆抗体以治疗潜在致命性败血症。
Sci Transl Med. 2020 Apr 15;12(539). doi: 10.1126/scitranslmed.aaz3833.
3
Sulforaphane Reduces HMGB1-Mediated Septic Responses and Improves Survival Rate in Septic Mice.莱菔硫烷可降低高迁移率族蛋白 B1 介导的脓毒症反应并提高脓毒症小鼠的生存率。
Am J Chin Med. 2017;45(6):1253-1271. doi: 10.1142/S0192415X17500690. Epub 2017 Aug 22.
4
Aloin Reduces HMGB1-Mediated Septic Responses and Improves Survival in Septic Mice by Activation of the SIRT1 and PI3K/Nrf2/HO-1 Signaling Axis.芦荟素通过激活 SIRT1 和 PI3K/Nrf2/HO-1 信号通路减轻高迁移率族蛋白 B1 介导的脓毒症反应并提高脓毒症小鼠的存活率。
Am J Chin Med. 2019;47(3):613-633. doi: 10.1142/S0192415X19500320. Epub 2019 Apr 9.
5
Role of high mobility group box 1 in inflammatory disease: focus on sepsis.高迁移率族蛋白 B1 在炎症性疾病中的作用：以脓毒症为例。
Arch Pharm Res. 2012 Sep;35(9):1511-23. doi: 10.1007/s12272-012-0901-5. Epub 2012 Oct 9.
6
Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.罂粟碱被鉴定为高迁移率族蛋白 B1/晚期糖基化终产物受体相互作用的抑制剂，可抑制高迁移率族蛋白 B1 介导的炎症反应。
Biochem Biophys Res Commun. 2019 Apr 9;511(3):665-670. doi: 10.1016/j.bbrc.2019.01.136. Epub 2019 Feb 27.
7
[Expression of high-mobility group box 1 in neonates with sepsis].[高迁移率族蛋白B1在脓毒症新生儿中的表达]
Zhongguo Dang Dai Er Ke Za Zhi. 2019 Feb;21(2):131-138. doi: 10.7499/j.issn.1008-8830.2019.02.005.
8
[Effect of dexmedetomidine on high-mobility group box 1 protein in rats with sepsis].右美托咪定对脓毒症大鼠高迁移率族蛋白B1的影响
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Sep;40(9):987-92. doi: 10.11817/j.issn.1672-7347.2015.09.007.
9
Ameliorative Effect of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) on HMGB1-Induced Septic Responses In Vitro and In Vivo.南非茶（Aspalathus linearis）中的安赛蜜和山柰酚对 HMGB1 诱导的体外和体内脓毒症反应的改善作用。
Am J Chin Med. 2015;43(5):991-1012. doi: 10.1142/S0192415X15500573. Epub 2015 Jul 30.
10
Associations between HMGB1 gene polymorphisms and susceptibility and clinical outcomes in Chinese Han sepsis patients.HMGB1 基因多态性与中国汉族脓毒症患者易感性及临床结局的关系。
Gene. 2019 Mar 1;687:23-29. doi: 10.1016/j.gene.2018.11.027. Epub 2018 Nov 10.
引用本文的文献
1
Identification of Two Critical Contact Residues in a Pathogenic Epitope from Tetranectin for Monoclonal Antibody Binding and Preparation of Single-Chain Variable Fragments.鉴定纤连蛋白致病表位中两个关键的单克隆抗体结合接触残基并制备单链可变片段
Biomolecules. 2025 Jul 30;15(8):1100. doi: 10.3390/biom15081100.
2
Synergistic tumor microenvironment modulation enabled by a nanozyme-boosted biomimetic macrophage-derived nanovesicle for highly efficient antitumor therapy.纳米酶增强的仿生巨噬细胞衍生纳米囊泡实现协同肿瘤微环境调节用于高效抗肿瘤治疗。
Theranostics. 2025 Jul 11;15(16):7925-7939. doi: 10.7150/thno.114467. eCollection 2025.
3
Exploring the prognostic and diagnostic value of lactylation-related genes in sepsis.探讨乳酰化相关基因在脓毒症中的预后和诊断价值。
Sci Rep. 2024 Oct 4;14(1):23130. doi: 10.1038/s41598-024-74040-0.
4
Research progress on miR-124-3p in the field of kidney disease.miR-124-3p 在肾脏疾病领域的研究进展。
BMC Nephrol. 2024 Aug 7;25(1):252. doi: 10.1186/s12882-024-03688-7.
5
Clinical Characteristics and Comparative Proteomics Analysis of COVID-19-Related Atrioventricular Block.新型冠状病毒肺炎相关房室传导阻滞的临床特征及比较蛋白质组学分析
Rev Cardiovasc Med. 2024 May 28;25(6):195. doi: 10.31083/j.rcm2506195. eCollection 2024 Jun.
6
Identification of sepsis-associated mitochondrial genes through RNA and single-cell sequencing approaches.通过RNA和单细胞测序方法鉴定脓毒症相关的线粒体基因。
BMC Med Genomics. 2024 May 3;17(1):120. doi: 10.1186/s12920-024-01891-x.
7
A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis.二十年来，人们一直在寻找高迁移率族蛋白 B1（HMGB1）和组织蛋白酶 L（pCTS-L）作为脓毒症潜在治疗靶点。
Expert Opin Ther Targets. 2023 Jul-Dec;27(7):575-591. doi: 10.1080/14728222.2023.2239495. Epub 2023 Jul 25.
8
Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock.鉴定脓毒症和感染性休克器官功能障碍和死亡相关的蛋白质组学特征。
PLoS One. 2022 Dec 2;17(12):e0278708. doi: 10.1371/journal.pone.0278708. eCollection 2022.
9
Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review.内源性调控与脓毒症诱导 HMGB1 释放及作用的药物调节：最新综述。
Cells. 2021 Aug 27;10(9):2220. doi: 10.3390/cells10092220.
10
CRISPLD2 attenuates pro-inflammatory cytokines production in HMGB1-stimulated monocytes and septic mice.CRISPLD2可减弱HMGB1刺激的单核细胞和脓毒症小鼠中促炎细胞因子的产生。
Am J Transl Res. 2021 May 15;13(5):4080-4091. eCollection 2021.
本文引用的文献
1
Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis.鉴定针对四连接蛋白的单克隆抗体以治疗潜在致命性败血症。
Sci Transl Med. 2020 Apr 15;12(539). doi: 10.1126/scitranslmed.aaz3833.
2
Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk.细胞焦亡：天然免疫与适应性免疫相互作用中的缺失拼图。
J Leukoc Biol. 2020 Jul;108(1):323-338. doi: 10.1002/JLB.3MIR0120-625R. Epub 2020 Feb 21.
3
Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012-2018.医疗保险受益人群中的败血症：1. 2012-2018 年败血症负担。
Crit Care Med. 2020 Mar;48(3):276-288. doi: 10.1097/CCM.0000000000004224.
4
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率，1990-2017 年：全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
5
Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic Review.哪些重症监护医学多中心随机对照试验显示降低了死亡率？系统评价。
Crit Care Med. 2019 Dec;47(12):1680-1691. doi: 10.1097/CCM.0000000000004000.
6
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation.HMGB1 拮抗剂盒 A、抗 HMGB1 抗体和胆碱能激动剂抑制 HMGB1/RAGE 介导的内吞作用，从而抑制炎症反应。
Mol Med. 2019 Apr 11;25(1):13. doi: 10.1186/s10020-019-0081-6.
7
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis.内毒素输送蛋白 HMGB1 介导脓毒症中 caspase-11 依赖性致死。
Immunity. 2018 Oct 16;49(4):740-753.e7. doi: 10.1016/j.immuni.2018.08.016. Epub 2018 Oct 9.
8
Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis.临床前期脓毒症研究的最低质量阈值 (MQTiPSS)：改善脓毒症动物模型的国际专家共识倡议。
Shock. 2018 Oct;50(4):377-380. doi: 10.1097/SHK.0000000000001212.
9
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动：脓毒症与脓毒性休克管理国际指南：2016版
Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255.
10
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义（脓毒症-3）》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
Zotero 插件